Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-16

Clinical Trial Update: To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic Rhinitis [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing levocetirizine with loratadine for the treatment of seasonal allergic rhinitis to evaluate efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levocetirizine (Levocetirizine)
  • Loratadine (Loratadine)

Snippet

Sponsor: UCB Pharma | Conditions: Rhinitis, Allergic | Phase 3 | Status: COMPLETED